Idofnib 100mg 10 Capsules

babies: it is not applicable. lactating mother: it is unsafe to use during breastfeeding.
before taking this medication, consult your doctor. pregnancy: it is unsafe to use during pregnancy.
before taking this medication, consult your doctor. driving: this medication may decrease alertness, affect your vision or make you feel sleepy and dizzy so, do not drive if these symptoms occur.
alcohol: it is not known safe or unsafe to consume alcohol with a idofnib capsule. kidney: use this medication with caution in patients with kidney disease.
dosage adjustment is required. consult your doctor before taking this idofnib capsule.
liver: use this medication with caution in patients with liver disease. dosage adjustment is required.
consult your doctor before taking this idofnib capsule..

diarrhea nausea abdominal pain abnormal liver function tests loss of appetite headache weight loss high blood pressure.

idofnib capsule is an anti-cancer medicine used to treat idiopathic pulmonary fibrosis and non-small cell lung cancer. it works by blocking the action of the abnormal protein that signals cancer cells to multiply and helps to stop or slow the spread of cancer cells..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• exercise moderately. eat healthily. • follow pulmonary rehabilitation program.
it includes exercise, disease education, and group therapy. • quit smoking and alcohol. • get ample rest. • include green leafy vegetables, sweet potatoes, broccoli, tomatoes, carrots, mangoes, citrus fruits, berries, and cocoa. • lean proteins such as fish, meat, and poultry are the best. • hydration is important. drink plenty of water, herbal tea, vegetable and fruit juices. • avoid processed and refined foods..

serious • idofnib + phenytoin: concurrent use of these drugs may result in decreased idofnib exposure. • idofnib + rifampicin: concurrent use of these drugs may result in decreased idofnib exposure. • idofnib + fondaparinux: concurrent use of these drugs may result in an increased risk of bleeding. • idofnib + warfarin: concurrent use of these drugs may result in an increased risk of bleeding..